Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Lia Scribano

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Gastroenterology|December 14, 2011
Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's diseaseCosimo Prantera, Herbert Lochs, Maria Grimaldi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 30, 2016
Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel DiseaseAlessandro Armuzzi, Paolo Gionchetti, Marco Daperno, et al.
Gastroenterology Research and Practice|November 8, 2018
Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life StudyDaniela Pugliese, Annalisa Aratari, Stefano Festa, et al.
Alimentary Pharmacology & Therapeutics|April 15, 2024
Crohn's disease after surgery: Changes in post-operative management strategies over time and their impact on long-term re-operation rate-A retrospective multicentre real-world studyAnnalisa Aratari, Maria Lia Scribano, Daniela Pugliese, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 4, 2018
Ustekinumab in the management of Crohn's disease: Expert opinionAlessandro Armuzzi, Sandro Ardizzone, Livia Biancone, et al.
Expert Opinion on Biological Therapy|July 15, 2020
Ustekinumab for treating ulcerative colitis: an expert opinionLivia Biancone, Sandro Ardizzone, Alessandro Armuzzi, et al.
Frontiers in Pharmacology|February 13, 2019
Sex Differences in Response to TNF-Inhibiting Drugs in Patients With Spondyloarthropathies or Inflammatory Bowel DiseasesBruno Laganà, Angelo Zullo, Maria Lia Scribano, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 10, 2018
Management of ulcerative colitis in a real-life setting: An Italian multicenter, prospective, observational AIGO studyMaria Lia Scribano, Claudio Papi, Francesco Costa, et al.
International Journal of Molecular Sciences|March 6, 2021
Vitamin D Signaling in Gastro-Rheumatology: From Immuno-Modulation to Potential Clinical ApplicationsCristiano Pagnini, Andrea Picchianti-Diamanti, Vincenzo Bruzzese, et al.
Therapeutic Advances in Gastroenterology|February 21, 2022
Effectiveness of ustekinumab in patients with refractory Crohn's disease: a multicentre real-life study in ItalyMaria Lia Scribano, Annalisa Aratari, Benedetto Neri, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Gastroenterology|December 14, 2011
Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's diseaseCosimo Prantera, Herbert Lochs, Maria Grimaldi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 30, 2016
Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel DiseaseAlessandro Armuzzi, Paolo Gionchetti, Marco Daperno, et al.
Gastroenterology Research and Practice|November 8, 2018
Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life StudyDaniela Pugliese, Annalisa Aratari, Stefano Festa, et al.
Alimentary Pharmacology & Therapeutics|April 15, 2024
Crohn's disease after surgery: Changes in post-operative management strategies over time and their impact on long-term re-operation rate-A retrospective multicentre real-world studyAnnalisa Aratari, Maria Lia Scribano, Daniela Pugliese, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 4, 2018
Ustekinumab in the management of Crohn's disease: Expert opinionAlessandro Armuzzi, Sandro Ardizzone, Livia Biancone, et al.
Expert Opinion on Biological Therapy|July 15, 2020
Ustekinumab for treating ulcerative colitis: an expert opinionLivia Biancone, Sandro Ardizzone, Alessandro Armuzzi, et al.
Frontiers in Pharmacology|February 13, 2019
Sex Differences in Response to TNF-Inhibiting Drugs in Patients With Spondyloarthropathies or Inflammatory Bowel DiseasesBruno Laganà, Angelo Zullo, Maria Lia Scribano, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 10, 2018
Management of ulcerative colitis in a real-life setting: An Italian multicenter, prospective, observational AIGO studyMaria Lia Scribano, Claudio Papi, Francesco Costa, et al.
International Journal of Molecular Sciences|March 6, 2021
Vitamin D Signaling in Gastro-Rheumatology: From Immuno-Modulation to Potential Clinical ApplicationsCristiano Pagnini, Andrea Picchianti-Diamanti, Vincenzo Bruzzese, et al.
Therapeutic Advances in Gastroenterology|February 21, 2022
Effectiveness of ustekinumab in patients with refractory Crohn's disease: a multicentre real-life study in ItalyMaria Lia Scribano, Annalisa Aratari, Benedetto Neri, et al.
Pageof 4